Gilleron M, Vercauteren J, Puzo G
Laboratoire de Pharmacologie et de Toxicologie Fondamentales, Centre National de la Recherche Scientifique, Toulouse, France.
J Biol Chem. 1993 Feb 15;268(5):3168-79.
Lipooligosaccharides (LOSs) have recently been proposed as markers of mycobacterial avirulence. They have been characterized in Mycobacterium kansasii cell wall and were investigated in Mycobacterium gastri since the distinction between the two mycobacterial species remains in some question. A set of unknown LOSs was isolated from M. gastri W471. The highly antigenic lipooligosaccharide, LOS-III, was purified and appeared in all the M. gastri strains investigated regardless of their morphology. Moreover, by enzyme-linked immunosorbent assay and chromatographic approaches, it was found that LOS-III unambiguously distinguished M. gastri from the opportunistic pathogen M. kansasii. The LOS-III structure was established from its native form using NMR spectroscopy. This strategy revealed the presence of a supplementary monosaccharide (X) which was not characterized by routine carbohydrate analysis. Its core structure, 3,6-dideoxy-alpha-hexopyranose, was established from the complete assignment of the 1H and 13C spectra by two-dimensional homonuclear (COSY, HOHAHA) and heteronuclear 1H-13C heteronuclear multiple quantum correlation spectroscopy (HMQC) and HMQC-HOHAHA spectroscopy. Due to the absence of a proton at C4, the key data of the C4 side chain structure came from the heteronuclear multiple bond correlation spectroscopy (HMBC) spectrum. It was revealed to be a C-alkyl chain of partial structure 1,3-dimethoxypropyl. From the HMBC spectrum, this novel C-branched monosaccharide was located at the nonreducing end of the LOS, while the putative reducing end was found to consist of a 2',4,6-triacylated alpha-alpha-trehalose. The following structure, based on the evidence presented in this paper, is proposed for LOS-III: Xp alpha(1-->3)L-Xylp beta(1-->4)3-O-Me-Rhap alpha(1-->3)D- Galp beta(1-->3)-D-Glcp beta(1-->4)2-O-acyl-D-Glcp-alpha(1<==>1)alpha 4,6-di-O- acyl-D-Glcp.
脂寡糖(LOSs)最近被提议作为分枝杆菌无致病性的标志物。它们已在堪萨斯分枝杆菌细胞壁中得到表征,并在胃分枝杆菌中进行了研究,因为这两种分枝杆菌之间的区分仍存在一些疑问。从胃分枝杆菌W471中分离出一组未知的LOSs。高抗原性脂寡糖LOS-III被纯化出来,在所研究的所有胃分枝杆菌菌株中均有出现,无论其形态如何。此外,通过酶联免疫吸附测定和色谱方法发现,LOS-III能明确区分胃分枝杆菌与机会致病菌堪萨斯分枝杆菌。利用核磁共振光谱从其天然形式确定了LOS-III的结构。该策略揭示了存在一种常规碳水化合物分析未鉴定出的额外单糖(X)。通过二维同核(COSY、HOHAHA)和异核1H-13C异核多量子相关光谱(HMQC)以及HMQC-HOHAHA光谱对1H和13C光谱的完全归属,确定了其核心结构为3,6-二脱氧-α-己吡喃糖。由于C4处没有质子,C4侧链结构的关键数据来自异核多键相关光谱(HMBC)谱。结果表明它是一个部分结构为1,3-二甲氧基丙基的C-烷基链。从HMBC谱中可知,这种新型的C-分支单糖位于LOS的非还原端,而推测的还原端由一个2',4,6-三酰化的α-α-海藻糖组成。基于本文提供的证据,提出了LOS-III的以下结构:Xpα(1→3)L-Xylpβ(1→4)3-O-Me-Rhapα(1→3)D-Galpβ(1→3)-D-Glcpβ(1→4)2-O-酰基-D-Glcp-α(1<==>1)α 4,6-二-O-酰基-D-Glcp。